Jiangsu Nanfang Medical Co (SHSE:603880) Tariff Resilience Score: 0/10 (As of Jul. 29, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603880 Jiangsu Nanfang Medical Co Ltd SHSE:603880
50 GF Score
Price ¥6.37
GF Value ¥4.71
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Jiangsu Nanfang Medical Co Tariff Resilience Score?

Jiangsu Nanfang Medical Co has the Tariff Resilience Score of 0, which implies that the company might have .

Jiangsu Nanfang Medical Co has

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Jiangsu Nanfang Medical Co might have .

Jiangsu Nanfang Medical Co  (SHSE:603880) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Jiangsu Nanfang Medical Co Tariff Resilience Score Related Terms

SHSE:603880
50GF Score
Jiangsu Nanfang Medical Co Ltd SHSE:603880
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Jiangsu Nanfang Medical Co (SHSE:603880) Overvalued in 2026?

Based on GuruFocus' analysis, Jiangsu Nanfang Medical Co stock appears to be overvalued. The current stock price of ¥6.37 is trading 35.2% above its estimated GF Value™ of ¥4.71. GuruFocus considers Jiangsu Nanfang Medical Co to be Significantly Overvalued.

Key valuation signals for SHSE:603880:

  • Tariff Resilience Score: 0
  • GF Value™: ¥4.71 vs. price of ¥6.37 (35.2% above fair value)
  • GF Score™: 50/100 with 3 warning signs

No single metric tells the full story. See the SHSE:603880 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Jiangsu Nanfang Medical Co Business Description

Address Guo Xiang Road, Economic Development Zone, Jiangsu Province, Wujin, CHN, 213149
Jiangsu Nanfang Medical Co Ltd is a domestic adhesive dressing production enterprise that integrates research and development, production, and sales. It produces a band-aid in China. The company is focused on the development of self-owned brand products such as first-aid kits, sports protection products, and care products on the basis of the original series of Miaoshou medical dressings.
50GF Score

Get the complete analysis for SHSE:603880

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥6.37
Price
¥4.71
GF Value